Acquisition-Related Amortization and Remeasurement - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended		12 Months Ended
	Dec. 29, 2022	May 31, 2022	Apr. 30, 2021	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Research And Development Arrangement Contract To Perform For Others [Line Items]
Acquisition-related amortization and remeasurement				$ 24,336	$ 14,757	$ (7,404)
License Agreement [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Consideration agreed to pay with additional payments contingent upon reaching future commercialization and revenue-based milestones	$ 200
Acquisition-related amortization and remeasurement						17,200
Initial payment accrued						200
Contingent Payment Upon Reaching FDA Milestone			$ 4,000
Amount Received for the year		$ 1,500	$ 500
Contingent consideration milestone obligation		$ 3,500
License Agreement [Member] | Other Current Liabilities [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Contingent consideration accrued					$ 1,000	$ 1,000